Guangdong Taienkang Pharmaceutical Co. Ltd Capital Reinvestment Ratio
Guangdong Taienkang Pharmaceutical Co. Ltd capital reinvestment ratio. Guangdong Taienkang Pharmaceutical Co. Ltd (301263) has a Capital Reinvestment Ratio of 0.77x as of December 2024, meaning it reinvests 1% of its operating cash flow (CN¥89.33 Million) in capital expenditures (CN¥68.55 Million). See cash generation quality of Guangdong Taienkang Pharmaceutical Co. L to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Guangdong Taienkang Pharmaceutical Co. Ltd (2019–2024)
Capital reinvestment ratio of Guangdong Taienkang Pharmaceutical Co. Ltd from 2019 to 2024. This chart tracks Guangdong Taienkang Pharmaceutical Co. Ltd's Capital Reinvestment Ratio across 6 annual periods. See 301263 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Guangdong Taienkang Pharmaceutical Co. Ltd Capital Reinvestment Ratio by Year (2019–2024)
Guangdong Taienkang Pharmaceutical Co. Ltd capital reinvestment ratio by year from 2019 to 2024. For the full cash flow conversion analysis, see cash flow conversion of Guangdong Taienkang Pharmaceutical Co. L.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.77x | CN¥89.33 Million | CN¥68.55 Million | ▼ -64.1% |
| 2023 | 2.14x | CN¥93.53 Million | CN¥200.01 Million | ▲ +254.1% |
| 2022 | 0.60x | CN¥148.81 Million | CN¥89.88 Million | ▲ +62.4% |
| 2021 | 0.37x | CN¥120.02 Million | CN¥44.65 Million | ▼ -49.9% |
| 2020 | 0.74x | CN¥125.53 Million | CN¥93.12 Million | ▲ +533.5% |
| 2019 | 0.12x | CN¥75.44 Million | CN¥8.83 Million | — |